FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015674908> ?p ?o ?g. }

• W3015674908 endingPage "661" @default.
• W3015674908 startingPage "652" @default.
• W3015674908 abstract "Purpose This prospective, nonrandomized, interventional phase 1-2 study investigated the individualization of elective node irradiation in clinically N0 head and neck squamous cell carcinoma by sentinel lymph node (SLN) mapping with single-photon emission computed tomography/computed tomography (SPECT/CT) and its impact on tumor control and radiation-related toxicity. Methods and Materials Forty-four patients with clinically N0 head and neck squamous cell carcinoma treated with definitive (chemo-)radiation therapy were imaged with SPECT/CT after 99mTc nanocolloid injection around the tumor. The neck levels containing up to the 4 hottest SLNs were selected for prophylactic irradiation. A comparative virtual planning was performed with the selection of neck levels based on the current international guidelines. Regional control was monitored as a function of the selected volume. Dosimetric data for the organs at risk were compared between the plans. Normal tissue complication probability (NTCP) rates were derived for xerostomia, dysphagia, and hypothyroidism to predict the clinical benefit and correlated to quality-of-life (QoL) assessments at 6 months. Results Sixteen percent of patients presented unpredicted lymphatic drainage, and 48% drained unilaterally. The nodal clinical target volume based on lymphoscintigraphy was smaller than the nodal clinical target volume based on international guidelines by a factor of 2 (P < .0001). After a median follow-up of 46 months, only 1 patient experienced a regional relapse in a nonirradiated area. Significant median dose reductions to organs at risk were observed, particularly to contralateral salivary glands in patients with unilateral drainage (14.6-28.1 Gy) and to the thyroid gland in all patients (22.4-48.9 Gy). Median NTCP reductions were observed for xerostomia (0.3% to 13.7%), dysphagia (1.7% to 10.8%), and hypothyroidism (14.0% to 36.1%). QoL at 6 months was improved, particularly in patients irradiated unilaterally. Conclusions Neck SLN mapping with SPECT/CT individualizes and reduces the elective nodal target volumes without compromising the regional control. The NTCP rates were reduced and favorable QoL were observed in all patients, particularly in the case of unilateral irradiation. This prospective, nonrandomized, interventional phase 1-2 study investigated the individualization of elective node irradiation in clinically N0 head and neck squamous cell carcinoma by sentinel lymph node (SLN) mapping with single-photon emission computed tomography/computed tomography (SPECT/CT) and its impact on tumor control and radiation-related toxicity. Forty-four patients with clinically N0 head and neck squamous cell carcinoma treated with definitive (chemo-)radiation therapy were imaged with SPECT/CT after 99mTc nanocolloid injection around the tumor. The neck levels containing up to the 4 hottest SLNs were selected for prophylactic irradiation. A comparative virtual planning was performed with the selection of neck levels based on the current international guidelines. Regional control was monitored as a function of the selected volume. Dosimetric data for the organs at risk were compared between the plans. Normal tissue complication probability (NTCP) rates were derived for xerostomia, dysphagia, and hypothyroidism to predict the clinical benefit and correlated to quality-of-life (QoL) assessments at 6 months. Sixteen percent of patients presented unpredicted lymphatic drainage, and 48% drained unilaterally. The nodal clinical target volume based on lymphoscintigraphy was smaller than the nodal clinical target volume based on international guidelines by a factor of 2 (P < .0001). After a median follow-up of 46 months, only 1 patient experienced a regional relapse in a nonirradiated area. Significant median dose reductions to organs at risk were observed, particularly to contralateral salivary glands in patients with unilateral drainage (14.6-28.1 Gy) and to the thyroid gland in all patients (22.4-48.9 Gy). Median NTCP reductions were observed for xerostomia (0.3% to 13.7%), dysphagia (1.7% to 10.8%), and hypothyroidism (14.0% to 36.1%). QoL at 6 months was improved, particularly in patients irradiated unilaterally. Neck SLN mapping with SPECT/CT individualizes and reduces the elective nodal target volumes without compromising the regional control. The NTCP rates were reduced and favorable QoL were observed in all patients, particularly in the case of unilateral irradiation." @default.
• W3015674908 created "2020-04-17" @default.
• W3015674908 creator A5012262790 @default.
• W3015674908 creator A5012748007 @default.
• W3015674908 creator A5019282234 @default.
• W3015674908 creator A5019841349 @default.
• W3015674908 creator A5026138281 @default.
• W3015674908 creator A5033115194 @default.
• W3015674908 creator A5044639491 @default.
• W3015674908 creator A5063359963 @default.
• W3015674908 creator A5075209568 @default.
• W3015674908 date "2020-07-01" @default.
• W3015674908 modified "2023-09-26" @default.
• W3015674908 title "Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study" @default.
• W3015674908 cites W1578600693 @default.
• W3015674908 cites W1768115947 @default.
• W3015674908 cites W1916078948 @default.
• W3015674908 cites W1968528263 @default.
• W3015674908 cites W1968952846 @default.
• W3015674908 cites W1981897521 @default.
• W3015674908 cites W1988260245 @default.
• W3015674908 cites W1988864189 @default.
• W3015674908 cites W1989207107 @default.
• W3015674908 cites W1998665067 @default.
• W3015674908 cites W2005574374 @default.
• W3015674908 cites W2005887998 @default.
• W3015674908 cites W2022147472 @default.
• W3015674908 cites W2041802539 @default.
• W3015674908 cites W2060562974 @default.
• W3015674908 cites W2060599323 @default.
• W3015674908 cites W2062144679 @default.
• W3015674908 cites W2066765026 @default.
• W3015674908 cites W2082841801 @default.
• W3015674908 cites W2087284528 @default.
• W3015674908 cites W2091940655 @default.
• W3015674908 cites W2097877264 @default.
• W3015674908 cites W2104783586 @default.
• W3015674908 cites W2112884386 @default.
• W3015674908 cites W2113210661 @default.
• W3015674908 cites W2116264492 @default.
• W3015674908 cites W2118772763 @default.
• W3015674908 cites W2126971343 @default.
• W3015674908 cites W2139979551 @default.
• W3015674908 cites W2148517717 @default.
• W3015674908 cites W2148754315 @default.
• W3015674908 cites W2158373399 @default.
• W3015674908 cites W2158953473 @default.
• W3015674908 cites W2214035636 @default.
• W3015674908 cites W2253311382 @default.
• W3015674908 cites W2512792914 @default.
• W3015674908 cites W2603779835 @default.
• W3015674908 cites W2802821733 @default.
• W3015674908 cites W2885320596 @default.
• W3015674908 cites W2911690798 @default.
• W3015674908 doi "https://doi.org/10.1016/j.ijrobp.2020.03.021" @default.
• W3015674908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32294522" @default.
• W3015674908 hasPublicationYear "2020" @default.
• W3015674908 type Work @default.
• W3015674908 sameAs 3015674908 @default.
• W3015674908 citedByCount "12" @default.
• W3015674908 countsByYear W30156749082020 @default.
• W3015674908 countsByYear W30156749082021 @default.
• W3015674908 countsByYear W30156749082022 @default.
• W3015674908 countsByYear W30156749082023 @default.
• W3015674908 crossrefType "journal-article" @default.
• W3015674908 hasAuthorship W3015674908A5012262790 @default.
• W3015674908 hasAuthorship W3015674908A5012748007 @default.
• W3015674908 hasAuthorship W3015674908A5019282234 @default.
• W3015674908 hasAuthorship W3015674908A5019841349 @default.
• W3015674908 hasAuthorship W3015674908A5026138281 @default.
• W3015674908 hasAuthorship W3015674908A5033115194 @default.
• W3015674908 hasAuthorship W3015674908A5044639491 @default.
• W3015674908 hasAuthorship W3015674908A5063359963 @default.
• W3015674908 hasAuthorship W3015674908A5075209568 @default.
• W3015674908 hasConcept C121608353 @default.
• W3015674908 hasConcept C126322002 @default.
• W3015674908 hasConcept C126838900 @default.
• W3015674908 hasConcept C141071460 @default.
• W3015674908 hasConcept C179671157 @default.
• W3015674908 hasConcept C188816634 @default.
• W3015674908 hasConcept C201645570 @default.
• W3015674908 hasConcept C2776530083 @default.
• W3015674908 hasConcept C2776833033 @default.
• W3015674908 hasConcept C2778474501 @default.
• W3015674908 hasConcept C2780212769 @default.
• W3015674908 hasConcept C2780849966 @default.
• W3015674908 hasConcept C2989005 @default.
• W3015674908 hasConcept C509974204 @default.
• W3015674908 hasConcept C530470458 @default.
• W3015674908 hasConcept C71924100 @default.
• W3015674908 hasConceptScore W3015674908C121608353 @default.
• W3015674908 hasConceptScore W3015674908C126322002 @default.
• W3015674908 hasConceptScore W3015674908C126838900 @default.
• W3015674908 hasConceptScore W3015674908C141071460 @default.
• W3015674908 hasConceptScore W3015674908C179671157 @default.
• W3015674908 hasConceptScore W3015674908C188816634 @default.
• W3015674908 hasConceptScore W3015674908C201645570 @default.
• W3015674908 hasConceptScore W3015674908C2776530083 @default.

• next